| Dexycu (dexamethasone intraocular injection) / EyePoint Pharma, Ocumension Therap |
NCT04184999: Effect of Intraoperative Dexamethasone on Post-op Dry Eye |
|
|
| Completed | 4 | 40 | US | dexamethasone intraocular suspension, 9%, Dexycu, Prednisolone Acetate 1% Oph Susp | SR Cornea Consultants | Dry Eye Syndromes | 12/19 | 12/19 | | |
NCT04273282: A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% |
|
|
| Completed | 4 | 31 | US | Dexycu intracameral dexamethasone, Moxifloxacin 0.5%, Prolensa, Prednisolone Acetate | Research Insight LLC | Cataract | 11/20 | 11/20 | | |
NCT04316936: Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery |
|
|
| Completed | 4 | 15 | US | Omidria, Dextenza (dexamethasone ophthalmic insert) 0.4mg, Dexycu, 9% Intraocular Suspension, Prednisolone Acetate 1% | Silverstein Eye Centers, Ocular Therapeutix, Inc. | Cataract Surgery | 12/20 | 12/20 | | |
NCT04781335: "A Prospective Study of the Efficacy of Intracameral Dexamethasone (Dexycu™) Compared to Standard of Care Treatment for Post-Cataract Surgical Pain and Anterior Chamber Inflammation" |
|
|
| Recruiting | 4 | 50 | US | Dexycu, Standard of Care post operative eye drops (steroid, antibiotic, NSAID) | The Eye Institute of West Florida, EyePoint Pharmaceuticals, Inc. | Cataract | 06/21 | 08/21 | | |
NCT05191706: Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract |
|
|
| Recruiting | 4 | 60 | US | Dexamethasone, Prednisolone Acetate Ophthalmic | EyePoint Pharmaceuticals, Inc. | Cataract | 01/25 | 02/25 | | |
